or Try an Advanced Search...

    Technical Analysis for NYR - Nyrada Inc.

    Grade Last Price % Change Price Change
    D 0.060 -7.69% -0.005
    NYR closed unchanged on Tuesday, May 14, 2024, on 13 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: May 16
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Down
    Historical NYR trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness -7.69%
    Wide Bands Range Expansion -7.69%
    Below Lower BB Weakness -7.69%
    Oversold Stochastic Weakness -7.69%
    Lower Bollinger Band Walk Weakness -7.69%
    Wide Bands Range Expansion -7.69%
    Below Lower BB Weakness -7.69%
    Lower Bollinger Band Touch Weakness -7.69%
    Oversold Stochastic Weakness -7.69%
    Jack-in-the-Box Bearish Bearish Swing Setup -16.67%
    Older End-of-Day Signals for NYR ...

       Recent Intraday Alerts

    Alert Time
    Gap Up Closed 7 minutes ago
    Reversed from Up 7 minutes ago
    Fell Below Previous Day's Low 7 minutes ago
    Outside Day 7 minutes ago
    Down 5% 7 minutes ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    NYR Chart by TradingView
    Basic chart:

    Profile

    Nyrada Inc (NYR) is a preclinical stage, drug development company. The Company specialises in the development of novel small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. It focuses on areas of substantial unmet clinical need and has identified drug candidates with therapeutic and commercial potential, where few if any, effective or well-tolerated therapies exist. It currently has three wholly-owned drug programs:
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Disease Diseases Drugs Drug Development

    Is NYR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.17
    52 Week Low 0.018
    Average Volume 6,288,882
    200-Day Moving Average 0.055
    50-Day Moving Average 0.098
    20-Day Moving Average 0.090
    10-Day Moving Average 0.080
    Average True Range 0.007
    RSI (14) 32.89
    ADX 29.1
    +DI 21.582
    -DI 39.551
    Chandelier Exit (Long, 3 ATRs) 0.093
    Chandelier Exit (Short, 3 ATRs) 0.087
    Upper Bollinger Bands 0.114
    Lower Bollinger Band 0.065
    Percent B (%b) 0.0
    BandWidth 55.357
    MACD Line -0.007
    MACD Signal Line -0.004
    MACD Histogram -0.0038
    Fundamentals Value
    Market Cap 7.12 Million
    Num Shares 109 Million
    EPS -99999.99
    Price-to-Earnings (P/E) Ratio 0.00
    Price-to-Sales 0.00
    Price-to-Book 4.35
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.071
    Resistance 3 (R3) 0.072 0.070 0.070
    Resistance 2 (R2) 0.070 0.069 0.070 0.070
    Resistance 1 (R1) 0.068 0.068 0.067 0.067 0.069
    Pivot Point 0.066 0.066 0.066 0.066 0.066
    Support 1 (S1) 0.064 0.065 0.063 0.063 0.061
    Support 2 (S2) 0.062 0.064 0.062 0.060
    Support 3 (S3) 0.060 0.062 0.060
    Support 4 (S4) 0.059